<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To discuss clinical effects and therapeutic mechanisms of Tianbaokang Injection on ischemic <z:e sem="disease" ids="C0038454" disease_type="Disease or Syndrome" abbrv="">apoplexy</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: 70 cases of ischemic <z:e sem="disease" ids="C0038454" disease_type="Disease or Syndrome" abbrv="">apoplexy</z:e> were divided into two groups at random(Tianbaokang group and contrast group, 38 and 32 cases respectively) </plain></SENT>
<SENT sid="2" pm="."><plain>Clinical effects and indexes of hemorheology and vascular endothelial oxidative injury(SOD activity, <z:chebi fb="14" ids="32506">MDA</z:chebi> content, NO level and ET-1 concentration) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The efficiency of Tianbaokang on ischemic <z:e sem="disease" ids="C0038454" disease_type="Disease or Syndrome" abbrv="">apoplexy</z:e> was 92.1% </plain></SENT>
<SENT sid="4" pm="."><plain>Tianbaokang can improve indexes of hemorheology, decrease plasm <z:chebi fb="14" ids="32506">MDA</z:chebi> and ET-1 content, and increase SOD activity and NO level obviously </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: Tianbaokang has better effects on ischemic <z:e sem="disease" ids="C0038454" disease_type="Disease or Syndrome" abbrv="">apoplexy</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The therapeutic mechanisms may be related to improving hemorheology, inhibiting <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation and vascular endothelial injury, and regulating endothelial function </plain></SENT>
</text></document>